The Link Between Benign Prostatic Hyperplasia and Sexual Dysfunction

被引：0
|
作者：
Xie D. [1 ]
Chughtai B. [1 ]
Elterman D.S. [1 ]
Seklehner S. [1 ,2 ]
Lee R. [1 ]
Te A.E. [1 ]
Kaplan S.A. [1 ,3 ,4 ]
机构：
[1] James Buchanan Brady Department of Urology, Weill Cornell Medical College of Cornell University, NY, NY
[2] Department of Urology, Landesklinikum Baden-Mödling, Baden
[3] Institute for Bladder and Prostate Health, Weill Cornell Medical College, NY, NY, 10065, 525 East 68th Street, F9West
[4] Iris Cantor Men's Health Center, New York Presbyterian Hospital, Weill Cornell Medical College, NY, NY, 10065, 425 East 61st Street
来源：
Current Bladder Dysfunction Reports | 2013年 / 8卷 / 3期
关键词：
Alpha blockers; BPH; ED; LUTS; PDE5Is; Sexual dysfunction;
D O I：
10.1007/s11884-013-0187-6
中图分类号：
学科分类号：
摘要：
Benign prostate hyperplasia (BPH) occurs in up to 50 % of men by age 50, and the incidence increases with age. The rate of erectile dysfunction (ED) in patients with BPH ranges from 30 to 70 %, but can be as high as 90.5 % in males aged over 50 years. BPH/lower urinary tract symptoms (LUTS) and sexual dysfunction (SD) can have a substantial negative impact on a man's quality of life (QoL). Symptom severity and impact on QoL in each condition increase when LUTS and ED coexist. Age and erection change in patients with LUTS could also correlate with ejaculation dysfunction. However, urologists and primary care physicians appear to under-recognize SD in men with BPH/LUTS. We review the mechanisms of action, association, and effect of treatment between BPH and ED. © 2013 Springer Science+Business Media New York.
引用
收藏
页码：229 / 235
页数：6
相关论文
共 50 条
  • [1] Assessment of sexual dysfunction in patients with benign prostatic hyperplasia
    Rosen, RC
    BJU INTERNATIONAL, 2006, 97 : 29 - 33
  • [2] Lower urinary tract symptoms, benign prostatic hyperplasia, and sexual dysfunction
    Park J.K.
    Köhler T.S.
    McVary K.T.
    Current Bladder Dysfunction Reports, 2008, 3 (4) : 233 - 240
  • [3] Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia
    Rosen, RC
    CURRENT OPINION IN UROLOGY, 2006, 16 (01) : 11 - 19
  • [4] Impact of medical treatments for benign prostatic hyperplasia on sexual function
    Giuliano, F
    BJU INTERNATIONAL, 2006, 97 : 34 - 38
  • [5] Assessment of prevalence of sexual dysfunction in patients having lower urinary tract symptoms with benign prostatic hyperplasia and effect of various treatment modalities on sexual function
    Mishra, Jagamohan
    Choudhury, Sunirmal
    Sinha, Subham
    Kundu, Gourab
    Mondal, Partha Protim
    Bera, Malay
    UROLOGIA JOURNAL, 2024, 91 (04) : 715 - 719
  • [6] Medical treatments for benign prostatic hyperplasia and sexual function
    Giuliano, Francois
    BJU INTERNATIONAL, 2008, 102 : 8 - 12
  • [7] The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia
    Gandhi, Jason
    Weissbart, Steven J.
    Smith, Noel L.
    Kaplan, Steven A.
    Dagur, Gautam
    Zumbo, Anna
    Joshi, Gargi
    Khan, Sardar Ali
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (02) : 295 - 304
  • [8] Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
    Gacci, Mauro
    Eardley, Ian
    Giuliano, Francois
    Hatzichristou, Dimitris
    Kaplan, Steven A.
    Maggi, Mario
    McVary, Kevin T.
    Mirone, Vincenzo
    Porst, Hartmut
    Roehrborn, Claus G.
    EUROPEAN UROLOGY, 2011, 60 (04) : 809 - 825
  • [9] Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction
    Kirby, RS
    O'Leary, MP
    Carson, C
    BJU INTERNATIONAL, 2005, 95 (01) : 103 - 109
  • [10] Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia
    Nehra, A
    BJU INTERNATIONAL, 2005, 96 (03) : 237 - 243
12345